Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kurage is a French healthtech company specializing in neuroprosthetics and functional electrical stimulation (FES) to restore mobility for individuals with motor disabilities. The company utilizes artificial intelligence to synchronize muscle stimulation with the user's movements, effectively acting as an "artificial nervous system." Their technology is applied in sports, rehabilitation, and daily life assistance for patients with spinal cord injuries or neuromuscular diseases. By bypassing damaged nerve pathways, Kurage's solutions enable paralyzed limbs to move and perform functional tasks. The company currently offers specialized exercise equipment for clinical settings and is developing wearable suits for broader mobility applications. Their approach aims to improve cardiovascular health and muscle tone while fostering neuroplasticity in patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kurage.